L-Tryptophan and 5-HTP: Benefits, Forms, Dosing, and Side Effects

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

L-Tryptophan is one of the nine essential amino acids, meaning the human body cannot synthesize it and must obtain it from dietary protein sources [1][2]. It is found in many protein-rich foods, including cheese, chicken, eggs, fish, milk, nuts, soy, tofu, and turkey. A typical 100 g (3.5 oz) serving of these foods provides 100-500 mg of L-tryptophan [3]. The estimated average requirement for adults is approximately 4 mg per kg of body weight per day (roughly 280 mg for a 70 kg individual), with the recommended dietary allowance set at approximately 5 mg/kg/day [4][5]. Typical adult intakes in omnivorous populations average 900-1,000 mg per day, well above minimum requirements [4].

5-Hydroxytryptophan (5-HTP, also known as L-5-hydroxytryptophan or oxitriptan) is a non-essential amino acid that is not found in appreciable amounts in the diet [3]. In the body, 5-HTP is synthesized from L-tryptophan as an intermediate step in the production of serotonin. In supplements, 5-HTP is typically extracted from seeds of Griffonia simplicifolia, a West African climbing shrub [3][6].

The Serotonin and Melatonin Pathway

Through a series of enzymatic steps, the body converts L-tryptophan into serotonin and melatonin — neurotransmitters that regulate mood, appetite, and sleep [2][3]:

• L-Tryptophan to 5-HTP: Tryptophan hydroxylase (TPH) catalyzes the rate-limiting step in serotonin biosynthesis, hydroxylating L-tryptophan to 5-HTP [7]. Two isoforms exist: TPH1 in peripheral tissues and TPH2 in the central nervous system [8].
• 5-HTP to Serotonin (5-HT): Aromatic L-amino acid decarboxylase (AADC) converts 5-HTP to serotonin [7]. 5-HTP can cross the blood-brain barrier, permitting direct access to the central nervous system for conversion to serotonin [3].
• Serotonin to Melatonin: In the pineal gland, serotonin is N-acetylated by arylalkylamine N-acetyltransferase (AANAT), then O-methylated to melatonin [9]. This process is under strong circadian control, with peak melatonin production during the dark phase [10].

Only a small fraction of dietary tryptophan — approximately 1-2% — enters the serotonin synthesis pathway [11]. The majority (approximately 90-95%) is metabolized via the kynurenine pathway, which produces neuroactive metabolites including kynurenic acid (neuroprotective) and quinolinic acid (neurotoxic), and contributes to NAD+ biosynthesis and niacin (vitamin B3) production [11][12]. The liver can also use tryptophan to produce niacin directly: approximately 60 mg of tryptophan yields 1 mg of niacin via the kynurenine pathway [4].

The Kynurenine Pathway

The kynurenine pathway constitutes the predominant catabolic route for tryptophan degradation. It is initiated by two rate-limiting enzymes: tryptophan 2,3-dioxygenase (TDO2), predominantly expressed in the liver, and indoleamine 2,3-dioxygenase (IDO1/IDO2), which predominates in peripheral tissues and is inducible by proinflammatory cytokines such as interferon-gamma [12][13]. Inflammatory conditions upregulate the pathway via cytokine-induced IDO expression, accelerating tryptophan-to-kynurenine conversion and depleting tryptophan available for serotonin synthesis [13][14]. The plasma kynurenine-to-tryptophan ratio is used as a biomarker of IDO activity and systemic inflammation [14].

Downstream metabolites include kynurenic acid (KYNA), which acts as an NMDA receptor antagonist with neuroprotective properties, and quinolinic acid (QUIN), an NMDA receptor agonist that can promote neurotoxicity and oxidative stress at elevated concentrations [12]. These metabolites also exert immunoregulatory effects, with kynurenine activating the aryl hydrocarbon receptor (AhR) to modulate T-cell function [15]. This pathway has significant implications for understanding the relationship between inflammation, tryptophan metabolism, and mood disorders.

Competition for Blood-Brain Barrier Transport

A critical factor in tryptophan's neurotransmitter functions is transport competition at the blood-brain barrier. Tryptophan crosses the BBB via the large neutral amino acid transporter (LAT1), where it competes with other large neutral amino acids, including branched-chain amino acids (leucine, isoleucine, valine), phenylalanine, and tyrosine [16][17]. This competition means that only approximately 1-3% of plasma tryptophan levels reach the brain under normal conditions [7]. Dietary carbohydrates can facilitate brain tryptophan uptake by stimulating insulin release, which preferentially clears competing amino acids from plasma while sparing tryptophan [18]. Conversely, high-protein meals increase competing amino acids, potentially reducing brain tryptophan availability despite providing more tryptophan overall [19]. This explains the persistent myth about turkey-induced drowsiness — turkey contains comparable tryptophan to chicken or beef, and the high protein content of a turkey meal actually increases amino acid competition [19].

Peripheral serotonin (approximately 90-95% of total body serotonin, produced primarily in enterochromaffin cells of the gastrointestinal tract) cannot cross the blood-brain barrier, necessitating independent central synthesis from tryptophan transported across the BBB [7][16].

Forms and Bioavailability

L-Tryptophan

L-Tryptophan is available as a single free-form amino acid supplement, typically at 500 mg per serving [3]. In food, tryptophan is bound to other amino acids within proteins and must be liberated through digestion before absorption. Supplemental L-tryptophan, being in free form, is absorbed more rapidly than protein-bound forms [4].

L-Tryptophan has a molecular weight of 204.23 g/mol and the molecular formula C11H12N2O2 [1]. It is characterized by an indole ring side chain that makes it the largest and most structurally complex of the standard proteinogenic amino acids [1]. It exhibits low water solubility (approximately 10.6 g/L at 20 degrees C) and is susceptible to photooxidation when exposed to ultraviolet or visible light [20].

Manufacturing and Sourcing

L-Tryptophan for supplements is produced primarily by microbial fermentation using genetically engineered strains of Escherichia coli or Corynebacterium glutamicum, which overexpress key enzymes in the tryptophan biosynthetic pathway, achieving production titers of 40-55 g/L [21][22]. Major suppliers include Ajinomoto (Japan), which produces the branded TryptoPure product, CJ CheilJedang (BestAmino brand), and Evonik (TrypAMINO/REXIVA) [22].

TryptoPure, manufactured by Ajinomoto, is noteworthy because it was the only L-tryptophan permitted for pharmaceutical import into the US from 1989 to 2005, following the eosinophilia-myalgia syndrome (EMS) outbreak associated with a different manufacturer (see Safety section) [3]. TryptoPure is manufactured under cGMP conditions using strains of E. coli or Corynebacteria, as opposed to the Bacillus amyloliquefaciens strain used by Showa Denko in the contaminated products that caused the EMS outbreak [23]. Several supplement products on the market indicate they use TryptoPure as their ingredient source.

Post-1989 manufacturing processes incorporate rigorous quality controls with HPLC and LC-MS monitoring of trace contaminants to ensure levels remain below 1 ppm, with minimum purity specifications of 98-99% for feed and pharmaceutical grades [21][22].

5-HTP

5-HTP is typically extracted from seeds of Griffonia simplicifolia [3][6]. Although it is possible to produce 5-HTP by fermentation (similar to L-tryptophan), extraction from Griffonia simplicifolia seeds is the more common commercial method. Consumers should look for products that list Griffonia simplicifolia seed as the source in the Supplement Facts panel [3].

5-HTP is a more expensive raw ingredient than L-tryptophan [3]. Due to high ingredient costs, some companies may cut corners. Be careful not to confuse any listed amount of Griffonia simplicifolia seed (from which 5-HTP is extracted) with the actual amount of 5-HTP, which will be a much smaller fraction of the seed weight [3].

L-Tryptophan vs. 5-HTP: Key Differences

Factor	L-Tryptophan	5-HTP
Dietary source	Abundant in protein-rich foods	Not found in appreciable amounts in diet
Supplement source	Fermentation (bacteria)	Extraction from Griffonia simplicifolia seeds
Metabolic position	Precursor to 5-HTP (one step further from serotonin)	Direct precursor to serotonin
BBB penetration	Competes with other amino acids at LAT1 transporter	Crosses the blood-brain barrier readily
Pathway flexibility	Can enter kynurenine pathway, niacin synthesis, protein synthesis	Committed to serotonin pathway
Typical supplement dose	500-1,000 mg	50-300 mg
Cost	Lower	Higher
EMS association	Historical cases (contamination-linked)	Rare cases reported (3 in France, 2001-2012)

L-Tryptophan has the advantage of versatility — it feeds into multiple metabolic pathways including protein synthesis, niacin production, and the kynurenine pathway, in addition to serotonin synthesis [2][4]. However, because tryptophan hydroxylase (the enzyme converting tryptophan to 5-HTP) is the rate-limiting step, and because tryptophan competes with other amino acids for brain entry, supplemental L-tryptophan is an indirect way to raise brain serotonin [7][16].

5-HTP bypasses both of these bottlenecks — it does not compete for brain transport at LAT1 and it enters the serotonin pathway downstream of the rate-limiting enzyme [3]. However, 5-HTP is committed exclusively to serotonin production and cannot contribute to protein synthesis or niacin production.

Evidence for Benefits

Sleep

L-Tryptophan for Sleep

L-Tryptophan has been studied as a sleep aid primarily for its ability to increase sleepiness and reduce the time needed to fall asleep (sleep onset latency), although it has not been shown to increase total sleep time [24].

A small study found that 1 g of L-tryptophan given 20 minutes before bedtime significantly reduced the time needed to fall asleep, and that lower doses (down to just 250 mg) also appeared to provide some benefit [25]. Doses higher than 1 g may also be effective.

A 2021 systematic review and meta-analysis of 10 RCTs (n=258 participants) concluded that daily L-tryptophan doses of 1 g or more improved subjective sleep quality metrics, including reduced wake-after-sleep onset, with a standardized mean difference of -0.56 versus placebo (P<0.05). Effects were negligible at doses below 1 g [26]. Subgroup analyses suggested slightly stronger benefits for maintenance insomnia subtypes, where awakenings decreased by up to 15%, but overall effect sizes remained modest (Hedges' g approximately 0.4) [26].

Best results have been found in people with mild insomnia or needing longer-than-average times to fall asleep. Results have been mixed or negative in entirely normal subjects, severe insomniacs, and people with serious medical or psychiatric illness [24].

Limitations of the sleep literature include small sample sizes (median n=20 per arm), short durations (1-4 weeks), and potential publication bias [27]. Long-term data beyond 3 months are sparse [27]. The American Academy of Sleep Medicine (updated 2017) does not endorse L-tryptophan as first-line therapy for insomnia, prioritizing cognitive behavioral therapy for insomnia (CBT-I) over nutraceuticals [27].

5-HTP for Sleep

Evidence for 5-HTP as a sleep aid is limited and based on small, older studies.

In healthy adults, two very small preliminary studies in the 1970s suggested certain sleep benefits. In one study, no significant increase in total sleep time was observed for four healthy young adults who took 200 mg of 5-HTP at bedtime or 5 hours before awakening, although there was a 7-53% increase in rapid eye movement (REM) sleep compared to baseline [28]. In the second study, among 8 healthy young adults, a higher dose (200 mg at 9:15 PM followed by 400 mg at 11:15 PM) produced similar results with no significant additional benefit [28]. Neither study involved statistical comparisons to a placebo group.

A study in the UK among 18 men and women (average age 67) with Parkinson's disease and REM sleep behavior disorder (RBD) found that 50 mg of 5-HTP, taken 30 minutes before bedtime daily for one month, modestly improved self-reported functioning during activities of daily living but did not significantly improve muscle atonia or reduce self-reported RBD frequency compared to placebo. However, there was a non-significant trend toward decreased RBD events, and the researchers suggested higher-dose trials may be warranted [29].

The recommended dose for sleep is 50-200 mg of 5-HTP once daily, taken 30 minutes to 2 hours before bedtime. Higher doses do not appear to provide greater benefit for sleep [3].

Depression

5-HTP for Depression

The primary clinical use of 5-HTP has been for depression, due to its ability to raise serotonin levels [3]. Several small studies have compared 5-HTP directly to standard antidepressants:

5-HTP vs. fluoxetine (Prozac): A small 8-week study among 60 people with a first depressive episode found 5-HTP to be of equal benefit to fluoxetine (an SSRI) for reducing the severity of depression when taken at a daily dosage of 150-400 mg in three divided doses. Side effects were similar between groups [30].

5-HTP vs. fluvoxamine (Luvox): A study among 63 adults with major depression showed that taking 100 mg of 5-HTP three times daily for 6 weeks had similar benefit to fluvoxamine (50 mg three times daily) for reducing depressed mood, anxiety, and physical symptoms, and 5-HTP caused fewer and less severe side effects [31].

However, drug comparison studies like these do not rule out a placebo effect. As there are no published, placebo-controlled studies of 5-HTP for treating depression, its role remains unproven [3].

L-Tryptophan for Depression

Limited human research suggests L-tryptophan might be useful for treating depression and seasonal affective disorder (SAD). Improvements in symptoms were reported in two of three people with treatment-resistant unipolar depression and borderline personality disorder given 1-2 g of L-tryptophan daily [32].

The Serotonin Hypothesis: A Critical Perspective

The rationale for using tryptophan or 5-HTP for depression rests on the monoamine hypothesis linking low serotonin to mood disorders. However, this hypothesis has been challenged:

Acute tryptophan depletion (ATD) paradigms, which transiently reduce brain serotonin synthesis by approximately 70-80% through dietary manipulation, demonstrate mood-lowering effects predominantly in remitted depressed patients or those with vulnerability factors (such as prior SSRI treatment), rather than in healthy or never-depressed individuals [33]. A meta-analysis of 25 studies involving 566 healthy volunteers found no significant mood-lowering effects from ATD [33].

A 2022 systematic umbrella review by Moncrieff et al., synthesizing multiple meta-analyses across 360 studies, concluded there is no consistent evidence associating depression with lowered serotonin activity, including from ATD studies and peripheral biomarkers [33]. This challenges the foundational rationale for tryptophan supplementation as an antidepressant.

A 2024 meta-analysis reported improvements in depression scores with tryptophan or 5-HTP, yet overall clinical trials in depressed patients show limited, non-replicable benefits, often confounded by small sample sizes and methodological variability [34][35]. A separate systematic review of 11 RCTs found that doses of 0.14-3 g/day of tryptophan may mildly enhance mood in healthy subjects, but lacked robust evidence for treating clinical depression [35].

Well-designed, placebo-controlled human studies are needed to determine whether L-tryptophan and 5-HTP are genuinely effective for depression [3][33].

Migraine Prevention

Some, but not all, studies have found that 5-HTP may help prevent migraines, although not tension headaches [36]. The typical dosage used in migraine studies has been 400-600 mg daily in divided doses [3]. Serotonin plays a known role in migraine pathophysiology, and 5-HTP's ability to raise serotonin levels provides the mechanistic rationale.

Weight Loss

Small studies of several weeks duration have indicated that 5-HTP may help with weight loss by causing people to consume fewer calories and feel full after eating [3].

In one study of 28 obese individuals (average age 43), taking 300 mg of 5-HTP three times daily (900 mg total) for 6 weeks without dieting caused a modest but statistically significant reduction in body weight (-3.7 lbs), while the placebo group showed no weight loss. The reduction appeared to be due to reduced energy and carbohydrate intake. When the same dose of 5-HTP was continued for an additional 6 weeks with calorie restriction, weight loss was even greater for the 5-HTP group (-7.2 lbs), while those taking placebo with calorie restriction showed no significant weight loss — an unusual finding that raises questions about the study design [37].

Fibromyalgia

One study suggested that 5-HTP can help people with fibromyalgia, a condition characterized by tender muscles, fatigue, and sleep disturbances that is often treated with antidepressants [3].

In this study, 200 participants with fibromyalgia were randomized to receive 400 mg of 5-HTP, the same dose of 5-HTP along with monoamine oxidase inhibitors (MAOIs — pargyline 5-10 mg daily or phenelzine 10-15 mg daily), MAOIs alone, or amitriptyline (10-50 mg daily). All treatments lasted 12 months and daily pain score was evaluated. All treatments led to reduced pain scores compared to baseline, and the researchers stated that improvement was greater for 5-HTP plus MAOIs compared to single treatments, although these analyses were not fully shown. About 8% of people in the 5-HTP groups reported stomachache [38]. Importantly, this study did not include a placebo control group, so it is not possible to confirm that 5-HTP was beneficial.

A separate pilot study involving 23 patients with fibromyalgia supplemented with coenzyme Q10, magnesium, and tryptophan reported reductions in pain and fatigue, though the exact tryptophan dose was not isolated and the sample size limited generalizability [39]. Earlier open-label studies using 5-HTP at doses of 100-300 mg daily over 90 days showed symptom improvement in primary fibromyalgia syndrome, suggesting a serotonergic mechanism [40].

Cognitive Function

A study in Singapore among 30 healthy older men and women (average age 66) showed that taking 100 mg of 5-HTP 20-30 minutes before bedtime daily for 12 weeks very slightly improved overall cognitive function compared to baseline (1-point improvement on a scale of 0 to 30), but this improvement was not significant compared to the placebo group — meaning there was no proven benefit. There were no between-group differences in language, delayed recall, attention, or executive function. 5-HTP also did not significantly improve mood. Those in the 5-HTP group showed a significant increase in blood serotonin levels compared to placebo (+45.8 vs. -20.2 ng/mL, respectively), but this did not translate into cognitive benefits [41].

Anxiety

In people with anxiety disorders, 5-HTP was found to be effective but not as effective as the drug clomipramine [42]. However, systematic reviews of tryptophan modulation, including depletion and loading paradigms, conclude that available studies lack power to confirm benefits, with no consistent effects on core anxiety symptoms [43].

Premenstrual Dysphoric Disorder (PMDD)

Some human research finds that L-tryptophan might help reduce feelings of unhappiness, irritability, and mood swings in women with premenstrual dysphoric disorder (PMDD) [3]. A 1999 placebo-controlled trial of 6 g daily L-tryptophan in 37 women with premenstrual dysphoric disorder reported modest reductions in dysphoria and irritability during the luteal phase, attributed to enhanced serotonin synthesis [44]. Effect sizes were small, and subsequent research has not yielded large confirmatory trials.

Smoking Cessation

Other human research indicates that L-tryptophan might help reduce cigarette cravings in people who are quitting smoking. The daily dose used was 50 mg/kg of L-tryptophan (approximately 4 g per day for an 80 kg person), taken together with a high-carbohydrate diet and conventional smoking cessation techniques [45]. A 1991 study found that this combination lowered self-reported anxiety and craving intensity versus controls during smoking cessation attempts [45]. Outcomes were subjective and short-term, with no long-term abstinence benefits demonstrated.

Sleep Apnea

Limited human research suggests that L-tryptophan might be useful for treating sleep apnea, although well-designed studies are needed to confirm this [3][24].

Recommended Dosing

L-Tryptophan Dosing by Indication

Indication	Daily Dose	Timing	Notes
Sleep aid	250 mg - 1 g	20 minutes before bedtime	Most common recommendation is 1 g at bedtime. Lower doses (250 mg) may also provide benefit [25]. Use lowest effective dose.
PMDD	6 g	Throughout the day	An extremely high dose; use only under medical supervision [44][46].
Smoking cessation	50 mg/kg (~4 g for 80 kg person)	Throughout the day	Combined with high-carbohydrate diet and conventional cessation techniques [45].
Depression	1-2 g	Divided doses	Limited evidence; well-designed trials needed [32].

5-HTP Dosing by Indication

Indication	Daily Dose	Timing	Notes
Depression	300 mg	100 mg three times daily	Best evidence from comparisons to fluoxetine and fluvoxamine [30][31].
Fibromyalgia	300 mg	100 mg three times daily	Based on limited evidence without placebo control [38][40].
Migraine prevention	400-600 mg	Divided doses	Some but not all studies show benefit [36].
Sleep	50-200 mg	30 min to 2 hours before bedtime	Higher doses do not appear to provide greater sleep benefit [3].
Weight loss	900 mg	300 mg three times daily	Based on one small study of 28 individuals [37].

Dietary Requirements

The estimated average requirement (EAR) for tryptophan in adults is 4 mg per kg of body weight per day, corresponding to approximately 280 mg daily for a 70 kg individual [4][5]. The recommended dietary allowance is typically set at 5 mg/kg/day. Requirements are higher during periods of rapid growth, infancy (up to 25 mg/kg/day in the first six months), and pregnancy (an additional 20-30% increment) [4].

Typical adult intakes in omnivorous US populations average approximately 977 mg/day for men and 679 mg/day for women [47]. Well-planned vegan and vegetarian diets typically deliver 800-900 mg daily through combinations of legumes, nuts, seeds, and whole grains, meeting requirements without supplementation [4].

General Guidance

For L-tryptophan as a sleep aid, it may be prudent to start with the lowest effective dose and increase only if needed. Doses above 1 g may be effective but carry higher risks of side effects [3][25]. Taking L-tryptophan with a carbohydrate-rich snack may enhance brain uptake by reducing competition from other amino acids at the blood-brain barrier [18].

Safety and Side Effects

L-Tryptophan Side Effects

Common side effects of L-tryptophan include [3][48]:

• Drowsiness
• Headache
• Heartburn and stomachache
• Nausea and vomiting
• Abdominal gas
• Diarrhea

At therapeutic doses (1-5 g daily), drowsiness is the most frequently reported effect due to enhanced serotonin and melatonin synthesis [48]. Nausea, dizziness, tremor, and headache occur more frequently at higher doses exceeding approximately 5 g for a 70 kg adult [48].

Acute toxicity is low, with oral LD50 values in rodents exceeding 5 g/kg. Subchronic rodent studies confirm no significant adverse effects at doses up to 2 g/kg/day [49].

L-Tryptophan can cause respiratory depression of the fetus and should not be used during pregnancy or while breastfeeding [3].

Eosinophilia-Myalgia Syndrome (EMS)

The 1989 Outbreak

In 1989, L-tryptophan supplements were associated with a serious medical condition called eosinophilia-myalgia syndrome (EMS), characterized by debilitating muscle pain and a high number of eosinophils (a type of white blood cell) in the blood [3][50]. While most patients recovered after withdrawal and treatment (typically with corticosteroids), cases of death or permanent disability were reported.

The FDA issued a Public Advisory against the use of L-tryptophan and recalled all over-the-counter dietary supplements containing 100 mg or more per daily dose. An import alert blocked foreign shipments of manufactured L-tryptophan. Eventually, more than 1,500 cases of EMS, including 38 deaths, were reported to the U.S. CDC, although the true incidence is thought to be much higher [3][50][51].

Cause: Contamination, Not Tryptophan Itself

Epidemiological studies traced the cause of EMS to consumption of L-tryptophan produced by the Japanese company Showa Denko that was contaminated with one or more unidentified substances [52]. According to one report from South Carolina, 29% of people who used that brand developed definite EMS, and the risk increased with dose: 13% at 250-1,500 mg/day, rising to 50% for doses over 4,000 mg/day [53].

The causal mechanism was traced to manufacturing impurities stemming from Showa Denko's process modifications to enhance yield, including the introduction of a genetically modified strain of Bacillus amyloliquefaciens for fermentation and reduced carbon treatment during purification [54]. Ongoing research identifies the most statistically significant contaminant, known as Peak AAA, as being formed by the reaction of L-tryptophan with fatty acids from bacterial cell membranes during the fermentation process [23].

Analytical chemistry confirmed these impurities were absent or minimal in pre-1988 batches and products from competitors using different microbial methods, supporting the conclusion that the contaminants — not the amino acid itself — were responsible [54][55].

Post-1989 Return to Market

With the passage of the Dietary Supplement Health and Education Act in 1994, L-tryptophan became available again as a supplement in the US if manufactured domestically. The import alert was cancelled in 2005 based on insufficient evidence to warrant detention without physically inspecting each foreign source [3].

Since the return to market, there has been one published case report of EMS associated with L-tryptophan (Allen, Arthritis & Rheumatism 2011) [56]. The case involved a 44-year-old woman in Illinois who developed symptoms within 3 weeks of starting 1,500 mg per day of L-tryptophan in early 2009. She developed swelling of the arms and legs, followed by muscle pain, weakness, and progressive skin thickening and hardening. Analysis of pills from the same lot showed no impurities, but the patient was found to have the HLA-DRB1*04 allele, a genetic risk factor for EMS among L-tryptophan users (increasing odds approximately 4-fold) [56].

The FDA has also received two other reports of possible EMS and two reports of muscle pain associated with L-tryptophan from January 2003 through August 2010 [3].

Role of Pure Tryptophan

Some cases of EMS occurred with L-tryptophan that was relatively pure (99.6%) or made by a company other than Showa Denko, suggesting that the amino acid itself may play a role in susceptible individuals [3][57]. One theory is that large doses of L-tryptophan as a single amino acid increase formation of metabolites that inhibit histamine destruction, which in turn can cause both eosinophilia and myalgia [57]. Other research suggests that people with functional somatic syndromes (fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, multiple chemical sensitivity) may be prone to develop an allergic reaction toward contaminants and, to a lesser extent, pure L-tryptophan, indicating an autoimmune reaction may be involved [58].

Talk with your healthcare provider before using L-tryptophan if you have kidney or liver disease, eosinophilia, or a condition involving your muscles. Stop using L-tryptophan and contact your healthcare provider if you develop symptoms of EMS, such as muscle pain, fatigue, nerve pain, rash, or skin changes [3].

5-HTP Side Effects

Side effects with 5-HTP have generally been limited to short-term, mild digestive distress (e.g., heartburn, nausea, diarrhea) and possible allergic reactions [3].

Unlike L-tryptophan, cases of EMS have not been reported with 5-HTP in the United States [3]. However, three cases of EMS (occurring between 2001 and 2012) associated with 5-HTP use have been reported in France, all involving individuals in their fifties [59]:

• One woman had taken 5-HTP for 3 years and developed scleroderma and itching.
• Another woman had taken 5-HTP for 1 year and developed joint pain, muscle weakness in all limbs, an "altered state," weight loss, and after another year on 5-HTP, fasciitis.
• A man taking 5-HTP for 1 year developed diffuse muscle pain and scleroderma.

The conditions of both women improved significantly after 5-HTP was stopped and corticosteroids were given. It is unclear if and how 5-HTP might cause EMS, and the occurrence is rare [59].

Peak X Concern

One report in 1998 discovered an unidentified substance termed "peak X" in a pharmaceutical product containing a combination of 5-HTP, tetrahydrobiopterin, and L-dopa/carbidopa. This raised concern because the substance was assumed to be similar to a contaminant found in L-tryptophan linked to EMS. However, better analytical testing has yet to confirm the presence of "peak X" in the "tainted" pharmaceutical product or other 5-HTP samples [60].

Serotonin Syndrome

Both L-tryptophan and 5-HTP increase serotonin levels and may increase the risk of serotonin syndrome — a serious, potentially life-threatening condition characterized by hyperthermia, autonomic instability, and altered mental status — when taken with drugs that also increase serotonin levels [3][61]. This includes antidepressants (SSRIs, SNRIs, MAOIs), dextromethorphan (Delsym), meperidine (Demerol), tramadol (Ultram), "triptan" anti-migraine drugs, and the supplement St. John's wort [3].

A case of mania was reported in an individual given 5-HTP (300 mg daily) who was taking antidepressants including the MAOI phenelzine, although it is uncertain to what extent 5-HTP contributed to the mania [62].

Special Populations

Pregnancy and Breastfeeding: L-Tryptophan can cause respiratory depression of the fetus and should not be used during pregnancy or while breastfeeding [3]. The safety of 5-HTP in pregnant or nursing women has not been established [3].

Children: Children have been given 5-HTP without harmful effects in some studies, but there is a concern that it could cause seizures in developmentally disabled children, e.g., those with Down's syndrome [3].

Kidney or Liver Disease: The safety of either supplement in those with liver or kidney disease has not been established [3].

Toxicity in Dogs

High doses of 5-HTP can cause a potentially fatal serotonin-like syndrome in dogs. A case was reported in a 17 lb Dachshund after ingesting 29 tablets of 5-HTP (each containing 100 mg of 5-HTP and 820 mg of xylitol, which is also toxic to dogs). The dog exhibited symptoms of serotonin syndrome and/or xylitol toxicosis, including agitation, seizures, rapid and irregular heartbeat, high blood pressure, low blood sugar, and coma. After three days of hospitalization the dog recovered [63]. Keep 5-HTP supplements out of reach of pets.

Test Interference

People who undergo a 24-hour urine 5-HIAA test (used to help diagnose carcinoid syndrome, a potentially life-threatening condition involving rare cancerous tumors that secrete serotonin) are typically advised to avoid tryptophan, and tryptophan-rich and serotonin-rich foods (pineapple, banana, kiwi, plum, tomato, walnut, hickory nut, eggplant) two to three days before this test [64]. There are at least three reported cases of people who had falsely elevated results on this test due to taking 100 mg of 5-HTP per day. Two to four weeks after supplementation was stopped, results were normal [65][66]. If you are prescribed this test, inform your healthcare provider and testing laboratory well in advance if you take L-tryptophan or 5-HTP.

Drug Interactions

Serotonergic Medications (Most Critical)

Both L-tryptophan and 5-HTP increase serotonin levels and should NOT be combined with serotonergic drugs without medical supervision due to risk of serotonin syndrome [3][61]:

Drug Class	Examples	Risk
SSRIs	Fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), escitalopram (Lexapro)	Serotonin syndrome — potentially life-threatening
SNRIs	Venlafaxine (Effexor), duloxetine (Cymbalta)	Serotonin syndrome
MAOIs	Phenelzine (Nardil), tranylcypromine (Parnate), selegiline	Serotonin syndrome — highest risk combination
Tricyclic antidepressants	Amitriptyline, nortriptyline, clomipramine	Serotonin syndrome
Triptan anti-migraine drugs	Sumatriptan, rizatriptan, eletriptan	Serotonin syndrome
Opioids	Meperidine (Demerol), tramadol (Ultram), fentanyl	Serotonin syndrome
Dextromethorphan	Delsym, Robitussin DM	Serotonin syndrome
Other supplements	St. John's wort	Additive serotonin effects

Carbidopa (Parkinson's Disease)

There is concern with using 5-HTP with carbidopa, as there are reports of this combination causing skin changes similar to those in scleroderma [3].

CNS Depressants

Central nervous system depressants such as sedatives or clonidine can exhibit enhanced sedative effects when combined with tryptophan, due to synergistic increases in serotonergic activity, potentially leading to excessive drowsiness or respiratory depression [67].

Branched-Chain Amino Acids (BCAAs)

BCAAs (leucine, isoleucine, valine) compete with tryptophan for transport across the blood-brain barrier via the LAT1 transporter, reducing brain tryptophan availability and subsequent serotonin synthesis [16][68]. Concurrent supplementation with high-dose BCAAs may reduce the effectiveness of tryptophan or 5-HTP supplementation.

Carbohydrate Interaction (Facilitative)

Dietary carbohydrates facilitate tryptophan uptake into the brain by stimulating insulin release, which preferentially clears competing large neutral amino acids from plasma. This is not an adverse interaction but can potentiate the effects of tryptophan supplementation [18].

Dietary Sources

Tryptophan in Foods

L-Tryptophan is found in many protein-rich foods. The table below shows approximate tryptophan content per 100 g of food [3][69][70]:

Food	Tryptophan (mg per 100 g)
Egg white, dried	1,000
Spirulina, dried	930
Cod, Atlantic, dried	700
Soybeans, mature, raw	590
Pumpkin seed kernels, raw	576
Cheese, Parmesan, shredded	560
Sesame seeds, toasted	370
Turkey, breast, meat and skin, cooked	330
Cheese, cheddar	320
Sockeye salmon, cooked	310
Sunflower seeds, toasted	300
Chicken, breast, meat and skin, raw	240
Pork chop, cooked, blade, lean only	240-410
Beef, rib eye, lean, raw	230
Salmon, Atlantic, wild, raw	220
Lamb, leg and sirloin, lean and fat, raw	210
Perch, Atlantic, raw	210
Beef, rib eye, lean, cooked	170-410
Egg, hard boiled	150
Wheat flour, white, all-purpose	130
Baking chocolate, unsweetened	130
Rice, white, long grain, raw	80
Milk, whole	70
Oatmeal, cooked	40
Potatoes, russet, raw	20
Banana	10

Source: USDA FoodData Central [3][69][70].

Practical Notes on Dietary Tryptophan

• Protein quality matters. Tryptophan constitutes approximately 1% of most food proteins, making it the rarest amino acid in proteomes [2][4]. High-quality animal protein sources generally provide more tryptophan per serving than plant sources.
• Maize is notably low. Reliance on untreated maize as a dietary staple provides only 0.5-1% tryptophan with reduced digestibility, contributing to niacin shortfall and historically to pellagra [4].
• Cooking preserves tryptophan. The amino acid is heat-stable under boiling or grilling, though high-temperature roasting (above 200 degrees C) can cause up to 20-30% degradation [71].
• Carbohydrate co-ingestion enhances brain delivery. Consuming tryptophan-rich foods with carbohydrates increases insulin-mediated clearance of competing amino acids, improving brain tryptophan uptake [18].
• The turkey myth. Turkey contains approximately 350 mg of tryptophan per 100 g — comparable to chicken (290 mg/100 g) and beef. Post-Thanksgiving drowsiness is more attributable to caloric overload, carbohydrate-induced insulin responses, and alcohol consumption than to tryptophan specifically [19].
• Vegan diets are typically adequate. Well-planned vegan diets relying on combinations of legumes, nuts, seeds, and whole grains typically deliver 800-900 mg of tryptophan daily, meeting requirements [4].

Conditions That Impair Tryptophan Status

• Hartnup disease: An autosomal recessive disorder caused by mutations in the SLC6A19 gene that impairs intestinal absorption and renal reabsorption of neutral amino acids, including tryptophan [72].
• Fructose malabsorption: Can impair tryptophan absorption [4].
• Inflammation: Proinflammatory cytokines upregulate the kynurenine pathway, diverting tryptophan away from serotonin synthesis and depleting available tryptophan [13][14].
• Severe malnutrition or chronic low-protein intake: Especially in populations reliant on tryptophan-poor staples [4].

References

1. National Center for Biotechnology Information. "L-Tryptophan | C11H12N2O2 | CID 6305." PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/6305

2. Palego L, et al. "Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans." J Amino Acids. 2016;2016:8952520. https://doi.org/10.1155/2016/8952520

3. ConsumerLab. "L-Tryptophan and 5-HTP Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/l-tryptophan-5-htp/tryptophan/

4. Grokipedia. "Tryptophan." https://grokipedia.com/page/Tryptophan

5. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: National Academies Press; 2005.

6. Birdsall TC. "5-Hydroxytryptophan: a clinically-effective serotonin precursor." Altern Med Rev. 1998;3(4):271-280. https://pubmed.ncbi.nlm.nih.gov/9727088/

7. Young SN, Gauthier S. "Tryptophan availability and the control of 5-hydroxytryptamine and tryptamine synthesis in human CNS." Adv Exp Med Biol. 1981;133:221-230. https://doi.org/10.1007/978-1-4684-3860-4_12

8. Walther DJ, et al. "Synthesis of serotonin by a second tryptophan hydroxylase isoform." Science. 2003;299(5603):76. https://doi.org/10.1126/science.1078197

9. Liu T, Borjigin J. "N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night." J Pineal Res. 2005;39(1):91-96. https://doi.org/10.1111/j.1600-079X.2005.00223.x

10. Klein DC, Weller JL. "Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltransferase." Science. 1970;169(3950):1093-1095. https://doi.org/10.1126/science.169.3950.1093

11. Badawy AA. "Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects." Int J Tryptophan Res. 2017;10:1178646917691938. https://doi.org/10.1177/1178646917691938

12. Schwarcz R, et al. "Kynurenines in the mammalian brain: when physiology meets pathology." Nat Rev Neurosci. 2012;13(7):465-477. https://doi.org/10.1038/nrn3257

13. Cervenka I, et al. "Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health." Science. 2017;357(6349):eaaf9794. https://doi.org/10.1126/science.aaf9794

14. Schroecksnadel K, et al. "Quality of life and immune activation in patients with HIV-infection." Brain Behav Immun. 2008;22(6):881-889. https://doi.org/10.1016/j.bbi.2007.12.011

15. Opitz CA, et al. "An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor." Nature. 2011;478(7368):197-203. https://doi.org/10.1038/nature10491

16. Fernstrom JD. "Large neutral amino acids: dietary effects on brain neurochemistry and function." Amino Acids. 2013;45(3):419-430. https://doi.org/10.1007/s00726-012-1330-y

17. Kanai Y, et al. "Expression cloning and characterization of a transporter for large neutral amino acids." J Biol Chem. 1998;273(37):23629-23632. https://doi.org/10.1074/jbc.273.37.23629

18. Wurtman RJ, Wurtman JJ. "Brain serotonin, carbohydrate-craving, obesity and depression." Obes Res. 1995;3(Suppl 4):477S-480S. https://doi.org/10.1002/j.1550-8528.1995.tb00215.x

19. Fernstrom JD, et al. "The ingestion of different dietary proteins by humans induces large changes in the plasma tryptophan ratio." Clin Nutr. 2013;32(6):1073-1076. https://doi.org/10.1016/j.clnu.2012.11.027

20. Fuentes-Lemus E, Davies MJ. Redox Biol. 2023;61:102615. https://doi.org/10.1016/j.redox.2023.102615

21. Ikeda M. "Towards bacterial strains overproducing L-tryptophan." Appl Microbiol Biotechnol. 2006;69(6):615-626. https://doi.org/10.1007/s00253-005-0252-y

22. Grokipedia. "Tryptophan — Industrial Synthesis and Manufacturing." https://grokipedia.com/page/Tryptophan

23. Klarskov K, et al. "Peak AAA fatty acid homolog contaminants present in the dietary supplement L-Tryptophan." Tox Letters. 2018;282:39-46. https://doi.org/10.1016/j.toxlet.2017.10.005

24. Hartmann E. "Effects of L-tryptophan on sleepiness and on sleep." J Psychiatr Res. 1982;17(2):107-113. https://doi.org/10.1016/0022-3956(82)90012-7

25. Hartmann E, Spinweber CL. "Sleep induced by L-tryptophan." J Nerv Ment Dis. 1979;167(8):497-499. https://doi.org/10.1097/00005053-197908000-00004

26. Sutanto CN, et al. "The impact of tryptophan supplementation on sleep quality." Nutr Rev. 2022;80(2):306-316. https://doi.org/10.1093/nutrit/nuab027

27. Sateia MJ, et al. "Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults." J Clin Sleep Med. 2017;13(2):307-349. https://doi.org/10.5664/jcsm.6470

28. Wyatt RJ, et al. "Effects of 5-hydroxytryptophan on the sleep of normal human subjects." Electroencephalogr Clin Neurophysiol. 1971;30(6):505-509. https://doi.org/10.1016/0013-4694(71)90147-7

29. Meloni M, et al. Sleep Breath. 2021;25(3):1493-1499. https://doi.org/10.1007/s11325-020-02198-y

30. Jangid P, et al. Asian J Psychiatr. 2013;6(1):29-34. https://doi.org/10.1016/j.ajp.2012.05.011

31. Poldinger W, et al. Psychopathology. 1991;24(2):53-81. https://doi.org/10.1159/000284698

32. Thomas SJ, et al. Adv Integ Med. 2015;2(1):23-29.

33. Moncrieff J, et al. "The serotonin theory of depression: a systematic umbrella review." Mol Psychiatry. 2023;28(8):3243-3256. https://doi.org/10.1038/s41380-022-01661-0

34. Soh NL, Walter G. Acta Neuropsychiatr. 2011;23(1):3-11. https://doi.org/10.1111/j.1601-5215.2010.00508.x

35. Shaw K, et al. "Tryptophan and 5-hydroxytryptophan for depression." Cochrane Database Syst Rev. 2002;(1):CD003198. https://doi.org/10.1002/14651858.CD003198

36. Jahromi SR, et al. Neurol Sci. 2019;40(11):2349-2355. https://doi.org/10.1007/s10072-019-03984-3

37. Cangiano C, et al. Am J Clin Nutr. 1992;56(5):863-867. https://doi.org/10.1093/ajcn/56.5.863

38. Nicolodi M, Sicuteri F. Recent Advances in Tryptophan Research. 1996;373-379. https://doi.org/10.1007/978-1-4613-0381-7_58

39. Cordero MD, et al. Nutrition. 2012;28(11-12):1200-1203. https://doi.org/10.1016/j.nut.2012.02.003

40. Caruso I, et al. J Int Med Res. 1990;18(3):201-209. https://doi.org/10.1177/030006059001800304

41. Li SM, et al. Nutrients. 2025;17(3):421. https://doi.org/10.3390/nu17030421

42. Kahn RS, et al. Int Clin Psychopharmacol. 1987;2(1):33-45. https://doi.org/10.1097/00004850-198701000-00003

43. Davies SJ, et al. J Psychopharmacol. 2006;20(6):41.

44. Steinberg S, et al. Adv Exp Med Biol. 1999;467:85-88. https://doi.org/10.1007/978-1-4615-4709-9_11

45. Bowen DJ, et al. J Behav Med. 1991;14(2):97-110. https://doi.org/10.1007/BF00844895

46. Steinberg S, et al. J Psychiatry Neurosci. 1994;19(2):114-119.

47. U.S. Department of Agriculture. "What We Eat in America, NHANES." https://fdc.nal.usda.gov/

48. Sidransky H. "Tryptophan: Biochemical and Health Implications." CRC Press. 2001.

49. European Food Safety Authority. EFSA Journal. 2024;22(2):e8578.

50. Swygert LA, et al. JAMA. 1990;264(13):1698-1703. https://doi.org/10.1001/jama.1990.03450130058029

51. Centers for Disease Control and Prevention. MMWR. 1989;38(45):785-788.

52. Back EE, et al. J Rheumatol. 1993;20(4):666-672. https://pubmed.ncbi.nlm.nih.gov/8496862/

53. Kamb ML, et al. JAMA. 1992;267(1):77-82. https://doi.org/10.1001/jama.1992.03480010085034

54. Slutsker L, et al. JAMA. 1990;264(2):213-217. https://doi.org/10.1001/jama.1990.03450020075024

55. Belongia EA, et al. N Engl J Med. 1990;323(6):357-365. https://doi.org/10.1056/NEJM199008093230601

56. Allen JA, et al. Arthritis Rheum. 2011;63(11):3633-3639. https://doi.org/10.1002/art.30514

57. Smith MJ, Garrett RH. Inflamm Res. 2005;54(11):435-450. https://doi.org/10.1007/s00011-005-1380-7

58. Barth H, et al. Clin Exp Immunol. 2001;124(2):303-310. https://doi.org/10.1046/j.1365-2249.2001.01509.x

59. Auffret M, et al. Fundam Clin Pharmacol. 2013;27(Suppl. 1):108. Abstract P2-204.

60. Das YT, et al. Toxicol Lett. 2004;150(1):111-122. https://doi.org/10.1016/j.toxlet.2003.12.070

61. Boyer EW, Shannon M. N Engl J Med. 2005;352(11):1112-1120. https://doi.org/10.1056/NEJMra041867

62. Pardo JS, et al. Gen Hosp Psychiatry. 2012;34(1):102.e13-14. https://doi.org/10.1016/j.genhosppsych.2011.05.016

63. Ortolani KL, et al. Clin Case Rep. 2019;7(5):1018-1023. https://doi.org/10.1002/ccr3.2140

64. Burks TF. AACE Clin Case Rep. 2016;2(4):e318-e320.

65. Preshaw PM, et al. CMAJ. 2008;178(3):305. https://doi.org/10.1503/cmaj.071289

66. Hallin ML, et al. Ann Clin Biochem. 2013;50(Pt 5):496-497. https://doi.org/10.1177/0004563213487793

67. National Library of Medicine. "Tryptophan: MedlinePlus Supplements." https://medlineplus.gov/druginfo/natural/326.html

68. Fernstrom JD, Fernstrom MH. J Nutr. 2007;137(6 Suppl 1):1539S-1547S. https://doi.org/10.1093/jn/137.6.1539S

69. U.S. Department of Agriculture. FoodData Central. https://fdc.nal.usda.gov/

70. USDA Nutrient Data. https://ndb.nal.usda.gov/ndb/

71. Mao X, et al. Int J Mol Sci. 2021;22(4):1526. https://doi.org/10.3390/ijms22041526

72. Nozaki J, et al. Biochem Biophys Res Commun. 2001;284(2):255-260. https://doi.org/10.1006/bbrc.2001.4961